Should you buy AKUMS.NS stock?
Last updated:
Based on market data through , StockInvest.us rates Akums Drugs & Pharmaceuticals Ltd. (AKUMS.NS) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. This is a downgrade from Strong Buy in the previous daily evaluation.
- Hold signal since
- Price since signal Up 35.05%
- 3-month trend forecast Up 35.68%
- Easy Tracking In The Watchlist
Weaker technical forecast for Akums Drugs & Pharmaceuticals Ltd. as stock downgraded to Hold/Accumulate
(Market data through Aug 10, 2026)
The Akums Drugs & Pharmaceuticals Ltd. stock price gained 4.65% on the last trading day (Monday, 10th Aug 2026), rising from ₹697.45 to ₹729.90. During the last trading day the stock fluctuated 7.66% from a day low at ₹703.00 to a day high of ₹756.85. The price has fallen in 6 of the last 10 days but is still up by 8.04% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately ₹1.59 billion.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 35.68% during the next 3 months and, with a 90% probability hold a price between ₹919.84 and ₹1,045.66 at the end of this 3-month period.
AKUMS.NS Signals & Forecast
The Akums Drugs & Pharmaceuticals Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at ₹680.42 and ₹662.11. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, July 31, 2026, and so far it has risen 10.87%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Akums Drugs & Pharmaceuticals Ltd. stock
Akums Drugs & Pharmaceuticals Ltd. finds support from accumulated volume at ₹702.05 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved ₹53.85 (7.66%) between high and low. For the last week, the stock has had daily average volatility of 3.98%.
Our recommended stop-loss: ₹702.31 (-3.78%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 6 days ago.)
Trading Expectations (AKUMS.NS) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Akums Drugs & Pharmaceuticals Ltd. to open at ₹729.92, and during the day (based on 14 day Average True Range), to move between ₹717.63 and ₹742.17, which gives a possible trading interval of +/-₹24.53 (+/-3.42%) up or down from last closing price. If Akums Drugs & Pharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 3.42% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ ₹702.05, some ₹27.85 (3.82%) from the current price of ₹729.90, our system finds the risk reward attractive.
Is Akums Drugs & Pharmaceuticals Ltd. stock A Buy?
Akums Drugs & Pharmaceuticals Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold candidate.
Current score:
0.000
Hold/Accumulate
Downgraded
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - ₹729.92 ( 0.0023%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
AKUMS.NS Performance
Trading levels for AKUMS.NS
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 783.77 | 7.38% |
| R2 | 763.20 | 4.56% |
| R1 | 750.49 | 2.82% |
| Price | 729.90 | |
| S1 | 709.35 | -2.82% |
| S2 | 696.64 | -4.56% |
| S3 | 676.07 | -7.38% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 729.90 | |
| S1 | 702.05 | -3.82% |
| S2 | 609.10 | -16.55% |
| S3 | 592.10 | -18.88% |
AKUMS Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Jul 03, 2026 | Jul 03, 2026 | Jul 03, 2026 | ₹2.70 | 0.495% |
FAQ
Click here for our free guide on how to buy Akums Drugs & Pharmaceuticals Ltd. Stock.
Buy AKUMS